2021 - Early Therapeutic Antibody Development: Addressing the Challenges to Expedite a CMC Program

Recommendations to prevent a drug development program from becoming a failure statistic
Understanding how to select variants that give you the best chance of manufacturing success
Discovering options for reducing timelines, whilst also mitigating risk
For More Information Please Visit: https://xtalks.com/webinars/early-therapeutic-anti...